Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria

<p><strong>Background</strong> In many endemic areas, Plasmodium vivax malaria is predominantly a disease of young adults and children. International recommendations for radical cure recommend fixed target doses of 0.25 or 0.5 mg/kg/day of primaquine for 14 days in glucose-6-phosph...

Full description

Bibliographic Details
Main Authors:	Taylor, WR, Hoglund, RM, Peerawaranun, P, Nguyen, TN, Hien, TT, Tarantola, A, von Seidlein, L, Tripura, R, Peto, TJ, Dondorp, AM, Landier, J, Nosten, FH, Smithuis, F, Phommasone, K, Mayxay, M, Kheang, ST, Say, C, Neeraj, K, Leang, R, Dysoley, L, Kheng, S, Muth, S, Roca-Feltrer, A, Debackere, M, Fairhurst, RM, Song, N, Buchy, P, Menard, D, White, NJ, Tarning, J, Mukaka, M
Format:	Journal article
Language:	English
Published:	BioMed Central 2021

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria

Similar Items